Daily Anesthesiology Research Analysis
Three impactful anesthesiology-related studies stood out today: a mechanistic paper elucidating an ATF5–GDF15 mitochondrial stress pathway underlying sevoflurane-induced neuroprotection against stroke; a meta-analysis establishing a clinically intuitive NNT of 4 for perioperative music to reduce anxiety; and a randomized trial showing remimazolam provides more stable hemodynamics than propofol during painless gastroscopy. Together, these works span mechanistic insight, implementation-ready nonph
Summary
Three impactful anesthesiology-related studies stood out today: a mechanistic paper elucidating an ATF5–GDF15 mitochondrial stress pathway underlying sevoflurane-induced neuroprotection against stroke; a meta-analysis establishing a clinically intuitive NNT of 4 for perioperative music to reduce anxiety; and a randomized trial showing remimazolam provides more stable hemodynamics than propofol during painless gastroscopy. Together, these works span mechanistic insight, implementation-ready nonpharmacologic care, and sedation pharmacology.
Research Themes
- Anesthetic-induced neuroprotection mechanisms (UPRmt, ATF5–GDF15)
- Nonpharmacologic perioperative anxiety management (music intervention, NNT)
- Sedation pharmacology and hemodynamic safety (remimazolam vs propofol)
Selected Articles
1. ATF5-Dependent GDF15 Expression Mediates Anesthesia-Induced Neuroprotection Against Stroke.
This mechanistic study links sevoflurane preconditioning to activation of the mitochondrial unfolded protein response (UPRmt), with ATF5-dependent upregulation of GDF15 mediating neuroprotection against ischemic stroke. The work provides a molecular framework that may explain inconsistent clinical translation of anesthetic preconditioning and suggests biomarkers (GDF15) and targets (ATF5/UPRmt) for future trials.
Impact: It uncovers a plausible, targetable pathway for anesthetic-induced neuroprotection, bridging basic mechanisms to perioperative stroke prevention strategies.
Clinical Implications: While preclinical, the ATF5–GDF15 axis and UPRmt activation could guide biomarker-driven patient selection and timing/dosing of anesthetic preconditioning, and motivate trials of perioperative strategies to reduce stroke risk.
Key Findings
- Sevoflurane-induced neuroprotection associates with upregulation of mitochondrial UPR (UPRmt) genes.
- ATF5-dependent induction of GDF15 is implicated as a mediator of anesthetic preconditioning against ischemic injury.
- The pathway offers mechanistic rationale and potential biomarkers/targets for translating anesthetic preconditioning.
Methodological Strengths
- Rigorous mechanistic focus linking anesthetic preconditioning to defined stress-response pathways (UPRmt).
- In vivo ischemia context supporting translational relevance of pathway activation.
Limitations
- Preclinical study; absence of human validation limits immediate clinical translation.
- Details on dosing, timing, and perioperative feasibility require dedicated clinical trials.
Future Directions: Prospective trials testing biomarker-guided anesthetic preconditioning (e.g., GDF15 levels) and modulation of ATF5/UPRmt in patients at high perioperative stroke risk.
Perioperative stroke is a rare but serious complication with a rising incidence in aging populations. Although preclinical studies consistently demonstrate that anesthetics such as sevoflurane can induce neuroprotective preconditioning against ischemic injury, clinical results have remained inconclusive. In this study, it is demonstrated that sevoflurane-induced neuroprotection is associated with the upregulation of genes involved in the mitochondrial unfolded protein response (UPR
2. The Number Needed to Treat for Music as a Medicine against Perioperative Anxiety: A Systematic Review and Meta-Analysis.
Across 20 randomized trials, perioperative music significantly reduced anxiety (SMD −0.72), translating to a Number Needed to Treat of 4 using Furukawa’s method. The magnitude of benefit aligns with benzodiazepines, providing clinicians with an implementation-ready, low-risk, nonpharmacologic option.
Impact: By quantifying benefit as an NNT, this meta-analysis lowers implementation barriers and informs shared decision-making for perioperative anxiety management.
Clinical Implications: Music can be integrated into preoperative, intraoperative, and postoperative pathways to reduce anxiety with minimal cost and risk; NNT=4 helps justify resource allocation and protocolization.
Key Findings
- Meta-analysis of 20 RCTs showed a moderate-to-large reduction in perioperative anxiety (SMD −0.72).
- Using Furukawa’s conversion, the Number Needed to Treat for music to meaningfully reduce anxiety is 4.
- Effect size is comparable to benzodiazepines, supporting music as an effective nonpharmacologic option.
Methodological Strengths
- Pre-registered multi-database search with inclusion of only randomized controlled trials.
- Risk-of-bias assessment and standardized conversion of effect sizes to NNT for clinical interpretability.
Limitations
- Heterogeneity across interventions, timing, and anxiety scales may influence pooled effects.
- Potential publication bias and variable blinding in included trials.
Future Directions: Standardize music intervention protocols (timing, duration, modality) and test in pragmatic trials assessing workflow integration and patient-centered outcomes.
BACKGROUND: Music intervention is effective in reducing perioperative anxiety, which occurs in a majority of hospitalized surgical patients. A calculated Number Needed to Treat (NNT) provides an intuitive means of conveying the effectiveness of an intervention that can help clinicians decide whether or not to implement said intervention. This study aimed to calculate an NNT to provide extra context to help clinicians consider the implementation of music intervention. METHODS: To calculate the NNT of music intervention for perioperative anxiety, a systematic review and meta-analysis were performed. A comprehensive literature search was conducted in Medline ALL, Embase, Web of Science Core Collection, Cochrane, CINAHL Plus, and PsycINFO from inception until April 14, 2025. Studies describing randomized controlled trials comparing the effect of perioperative music intervention on perioperative anxiety, measured with any validated tool, were included. The revised Cochrane risk-of-bias handbook was used to determine the quality of the included studies. The NNT was calculated with Furukawa's method, converting a calculated Cohen's d to an NNT. RESULTS: Twenty papers were included in the review and meta-analysis. All studies used either the Visual Analog Scale for Anxiety or the 6-item State-Trait Anxiety Index. Standardized mean difference of anxiety reduction after music interventions was -0.72 (95% confidence interval [CI], -0.92 to -0.53), which equals a moderate-to-large effect size. The NNT for perioperative music intervention is 4. This indicates that 4 patients need to listen to music perioperatively, to reduce the Visual Analog Scale for Anxiety for 1 patient by 12 mm, or the State-Trait Anxiety Index by 5.7 points. CONCLUSIONS: This meta-analysis shows that a relatively low number of patients need to be treated with music intervention to reduce perioperative anxiety with an effectiveness similar to benzodiazepines.
3. Comparative effects of remimazolam and propofol on hemodynamic stability during sedation for painless gastroscopy: a randomized clinical trial.
In a single-center randomized, single-blind trial (n=300), remimazolam maintained higher mean arterial pressure and reduced hypotension, bradycardia, and hypoxia compared with propofol during painless gastroscopy, while providing effective sedation. Continuous non-invasive arterial pressure monitoring corroborated superior hemodynamic stability with remimazolam.
Impact: Findings directly inform sedative selection for endoscopy, favoring remimazolam in patients at risk for hypotension or hypoxia.
Clinical Implications: Consider remimazolam as a first-line sedative for upper GI endoscopy when hemodynamic stability is prioritized; incorporate CNAP monitoring to detect transient instability.
Key Findings
- Remimazolam maintained higher mean arterial pressure compared with propofol at predefined timepoints.
- Significantly fewer episodes of hypotension, bradycardia, and hypoxia occurred with remimazolam.
- Both agents achieved effective sedation, supporting safety prioritization in sedative choice.
Methodological Strengths
- Randomized, single-blind design with adequate sample size (n=300).
- Continuous non-invasive arterial pressure monitoring improving detection of hemodynamic events.
Limitations
- Single-center design and single-blind methodology may limit generalizability and introduce performance bias.
- Sedation adjuncts and procedural variability may influence outcomes; longer-term outcomes were not assessed.
Future Directions: Multicenter, double-blind trials across endoscopic indications to confirm safety signals and define risk-stratified sedative algorithms.
BACKGROUND: Remimazolam, a novel ultra-short-acting benzodiazepine, shows promise for sedation in endoscopic procedures. However, its cardiovascular effects during painless gastroscopy remain unclear. This study compared the effects of remimazolam and propofol on hemodynamic stability in patients undergoing painless gastroscopy using continuous non-invasive arterial pressure (CNAP) monitoring. METHODS: A total of 300 patients scheduled for sedation during upper gastrointestinal endoscopy were randomly assigned to either the remimazolam group (Group R, RESULTS: At both assessment points, MAP was significantly higher in Group R than in Group P (82.5 vs. 75.0 mmHg at T1, CONCLUSION: Both remimazolam and propofol provide effective sedation for painless gastroscopy. However, remimazolam offers superior hemodynamic stability and significantly fewer adverse events. TRIAL REGISTRATION: The study was subsequently documented in the Chinese Clinical Trial Registry (identifier: ChiCTR2300068901; registration date: March 1, 2023). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12871-025-03484-2. UNLABELLED: This single-center, prospective, randomized, single-blind study compared the cardiovascular effects of remimazolam and propofol during painless gastroscopy. Our findings demonstrated that remimazolam provided superior hemodynamic stability compared to propofol, with significantly lower incidences of hypotension, bradycardia, and hypoxia compared to propofol.